<http://webisa.webdatacommons.org/149526582>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/149526582>	<http://www.w3.org/ns/prov#value>	"Factors that may reduce drug concentrations of crizotinib include administration with CYP 3A inducers and drugs such as proton pump inhibitors, histamine2 blockers, and antacids." .
<http://webisa.webdatacommons.org/prov/74487926>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/149526582> .
<http://webisa.webdatacommons.org/149526582>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<advanceweb.com> .
<http://webisa.webdatacommons.org/prov/151398786>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/149526582> .